Elfreda Dzukey

Department of Pharmacy, Campbell University College of Pharmacy & Health Sciences, Buies Creek, NC, USA · ROR

ORCID: 0000-0000-0000-0000

本刊中的主题: Aspirin, Chronic coronary syndrome, Clinical trial, Coronary artery disease, Direct oral anticoagulants, Glucagon-like peptide-1 receptor agonists, Glucose-dependent insulinotropic polypeptide, Heart failure with preserved ejection fraction · RSS

在 The Ulutas Medical Journal 发表的文章 (2)

  1. Aspirin Plus Oral Anticoagulation in High-Risk Patients with Stable Coronary Artery Disease After Percutaneous Coronary Intervention Stenting: Important Lessons Learned from the AQUATIC Trial
    2026 · doi:10.5455/umj.20260104053745
  2. Role for GLP-1 Agonists in Patients with Obesity and Heart Failure with Preserved Ejection Fraction
    2025 · doi:10.5455/umj.20250429034140

本刊合作者

这是您的页面吗?如需更正或要求隐藏,请告知编辑部。 告诉编辑

欢迎投来您的下一篇文章

投稿 作者须知

WhatsApp 告诉编辑
投稿 联系我们